Cardiovascular safety of Osimertinib in non-small cell lung cancer patients

被引：0
|
作者：
Chavan, Ashish [1 ]
Shirsat, Aditi [1 ]
Chopade, Sunil [1 ]
Menon, Nandini [1 ]
Patil, Vijay [1 ]
Noronha, Vanita [1 ]
Gota, Vikram [1 ]
Prabhash, Kumar [1 ]
Nookala, Manjunath [1 ]
机构：
[1] Tata Mem Hosp, Actrec, Parel, India
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0858
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [31] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [32] Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
    Galli, Giulia
    De Toma, Alessandro
    Pagani, Filippo
    Randon, Giovanni
    Trevisan, Benedetta
    Prelaj, Arsela
    Ferrara, Roberto
    Proto, Claudia
    Signorelli, Diego
    Ganzinelli, Monica
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina Chiara
    Lo Russo, Giuseppe
    LUNG CANCER, 2019, 137 : 38 - 42
  • [33] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer
    Zhong, Yuejiao
    Wei, Qiang
    Lu, You
    Tang, Xiuliang
    Wang, Zhongqiu
    Chen, Lingxiang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6016 - 6022
  • [34] Efficacy and Safety of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer
    Galli, G.
    De Toma, A.
    Pagani, F.
    Randon, G.
    Trevisan, B.
    Prelaj, A.
    Ferrara, R.
    Proto, C.
    Signorelli, D.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S454 - S454
  • [35] Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
    van Veggel, B.
    Santos, J. F. Vilacha Madeira R.
    Hashemi, S. M. S.
    Paats, M. S.
    Monkhorst, K.
    Heideman, D. A. M.
    Groves, M.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    van der Wekken, A. J.
    de Langen, A. J.
    LUNG CANCER, 2020, 141 : 9 - 13
  • [36] Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer
    Yamazaki, Mizuki
    Komizo, Nao
    Iihara, Hirotoshi
    Hirose, Chiemi
    Yanase, Komei
    Yamada, Yuto
    Endo, Junki
    Yamashita, Shuji
    Ohno, Yasushi
    Todoroki, Kenichiro
    Suzuki, Akio
    Hayashi, Hideki
    ANTICANCER RESEARCH, 2023, 43 (02) : 725 - 732
  • [37] The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Guven, Deniz Can
    Sahin, Taha Koray
    Kilickap, Saadettin
    CANCERS, 2024, 16 (01)
  • [38] Efficacy of Osimertinib in Patients of Advanced Non-Small Cell Lung Cancer with Brain Metastasis: A Retrospective Analysis
    Zhang, J.
    Chen, L.
    Ye, M.
    Li, H.
    Zhou, C.
    Pan, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S911 - S912
  • [39] Osimertinib in Patients With Non-Small Cell Lung Cancer and Uncommon EGFR Mutations-Chasing Unicorns?
    Wang, Victoria E.
    Gainor, Justin F.
    JAMA ONCOLOGY, 2024, 10 (01) : 52 - 53
  • [40] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Fu, Kai
    Xie, Fachao
    Wang, Fang
    Fu, Liwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
12345